Tim Greaney

Thomas (Tim) Greaney, JD, is a Visiting Professor of Law at UC Hastings College of Law in San Francisco and Distinguished Senior Fellow with the UC Hastings/UCSF Consortium on Law, Science & Health Policy. He is also Chester A. Myers Emeritus Professor of Law at Saint Louis University School of Law where he served as Director of the Center for Health Law Studies. His research focuses on the application of antitrust law to the health care sector, health care financing, and health care law and policy. He has written over 60 scholarly articles and chapters and is co-author of the nation’s leading health law casebook, HEALTH LAW: CASES, MATERIALS AND PROBLEMS (West, 8th edition 2018) and a treatise on health law, HEALTH LAW (WEST 3RD ED. 2014). He has testified on health care competition issues before the Judiciary Committees of the United States Senate and House of Representatives, the California Department of Insurance, and has spoken at workshops of the Federal Trade Commission. He has commented on health policy and law issues in the New York Times, Wall Street Journal and many other publications. Before entering academia, he served as an Assistant Chief in the U.S. Department of Justice Antitrust Division, supervising health care antitrust litigation. Professor Greaney has been named Health Law Professor of the Year by the American Society of Law and Medicine and has been a Fulbright Fellow studying European Community competition law in Brussels, Belgium. He received his B.A. from Wesleyan University and his J.D. from Harvard Law School.

Invigorating Competition in Health Care Markets: Is Rate Regulation Needed?

It now appears that market concentration may be the leading cause of America’s health care cost crisis. If the United States is...

Latest news

Creation over Time in Copyright and Patent

On May 18, the United States Supreme Court decided two intellectual property cases with two seemingly different results. A closer look, however, reveals a complimentary concern with the monopolistic power of first movers and how the legal system should enable innovation from second movers over time, writes Randy Picker.

ESG Standards’ Good, Bad and Ugly

The Stigler Center for the Study of the Economy and the State hosted a virtual event discussing the standards, metrics and disclosures of investments focused on Environmental, Social and Governance (ESG) goals. The following is a transcript of the event.


Lee Hepner and William J. McGee respond to Clifford Winston’s ProMarket piece asserting that further deregulation of the airline industry would resolve problems in the industry. Instead, the authors claim a return to regulation would produce better results for travelers.

A World With Far Fewer Mergers

Brooke Fox and Walter Frick analyze research and ideas presented at the Stigler Center Antitrust and Competition Conference that question the value of mergers.

The Banking Risks of Central Bank Digital Currencies

The implementation of central bank digital currencies as the primary medium of exchange would exacerbate the flaws of our current fiat system which encourage banks to overextend credit and create liabilities that they cannot redeem. This will worsen the already recurring cycles of financial crises, writes Vibhu Vikramaditya.

The Whig History of the Merger Guidelines

A pervasive "Whig" view of United States antitrust history among scholars and practitioners celebrates the Merger Guidelines' implementation of increasingly sophisticated economic methods since their...

Algorithmic Collusion in the Housing Market

While the development of artificial intelligence has led to efficient business strategies, such as dynamic pricing, this new technology is vulnerable to collusion and consumer harm when companies share the same software through a central platform. Gabriele Bortolotti highlights the importance of antitrust enforcement in this domain for the second article in our series, using as a case study the RealPage class action lawsuit in the Seattle housing market.